Daisy Graca

Nice, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

p16High immune cells control disease tolerance as a defense and health span-extending strategy.

p16High immune cells control disease tolerance as a defense and health span-extending strategy.

Journal: Immunity

Published: August 06, 2024

p16High immune cell - controlled disease tolerance as a broad defense and healthspan extending strategy.

p16High immune cell - controlled disease tolerance as a broad defense and healthspan extending strategy.

Journal: bioRxiv : the preprint server for biology

Published: July 19, 2024

Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.

Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.

Journal: Kidney international reports

Published: June 29, 2023

Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France.

Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France.

Journal: Journal of clinical immunology

Published: January 20, 2023

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses.

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses.

Journal: Frontiers in immunology

Published: January 16, 2023

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study.

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study.

Journal: Frontiers in immunology

Published: January 03, 2023

Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy.

Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: November 04, 2022

Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease.

Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 19, 2022

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients.

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients.

Journal: Frontiers in immunology

Published: May 26, 2022

Air pollution exposure induces a decrease in type II interferon response: A paired cohort study.

Air pollution exposure induces a decrease in type II interferon response: A paired cohort study.

Journal: EBioMedicine

Published: May 10, 2022

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.

Journal: Frontiers in immunology

Published: January 21, 2022

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies.

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies.

Journal: Nature communications

Published: September 13, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026